Medicinal chemistry agreement to focus on antivirals

Toronto, ON – Dalton Medicinal Chemistry Partners, the medicinal chemistry arm of Dalton Pharma Services, says it has signed a medicinal chemistry agreement with Boehringer Ingelheim (Canada).

Under the agreement, Dalton says it will design and synthesize novel compounds against a number of antiviral targets selected by Boehringer.